General Information of the Compound
Compound ID
CP0313065
Compound Name
4-cyclohexyloxy-2-[1-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]ethyl]quinazoline
    Show/Hide
Structure
Formula
C27H34N4O4S
Molecular Weight
510.66
Canonical SMILES
COc1ccc(cc1)S(=O)(=O)N1CCN(CC1)C(C)c1nc(OC2CCCCC2)c2ccccc2n1
    Show/Hide
InChI
InChI=1S/C27H34N4O4S/c1-20(30-16-18-31(19-17-30)36(32,33)23-14-12-21(34-2)13-15-23)26-28-25-11-7-6-10-24(25)27(29-26)35-22-8-4-3-5-9-22/h6-7,10-15,20,22H,3-5,8-9,16-19H2,1-2H3
    Show/Hide
InChIKey
FJNFVCAHHFNREI-UHFFFAOYSA-N
Physicochemical Property
logP
4.4174
Rotatable Bonds
7
Heavy Atom Count
36
Polar Areas
84.86
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11957831
SID: 17405951
ChEMBL ID
CHEMBL1257047
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 2187.76 nM
   TI
   LI
   LO
   TS
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 2200 nM
   TI
   LI
   LO
   TS